Evolving Industry Partnerships and Investments in Cell and Gene Therapies

Publication date: Available online 12 April 2018
Source:Cell Stem Cell
Author(s): Devyn M. Smith, Emily J. Culme-Seymour, Chris Mason
Cell and gene therapies hold the promise of providing significant and durable health gains to patients in many disease states and have recently elicited significant investor and partner interest. We cover the current state of industry partnerships and investments, highlight what makes a partnership advantageous, and discuss implications for stem cell therapies.

Teaser

Cell and gene therapies hold the promise of providing significant and durable health gains to patients in many disease states and have recently elicited significant investor and partner interest. We cover the current state of industry partnerships and investments, highlight what makes a partnership advantageous, and discuss implications for stem cell therapies.


https://ift.tt/2IRgYeN